Skip to content

Ultrasound-Based Imaging Using the Aixplorer System in Diagnosing Prostate Cancer in Patients Undergoing Biopsy

Evaluation of the Aixplorer Ultrasound System for Evaluation of the Prostate

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03013413
Enrollment
99
Registered
2017-01-06
Start date
2011-09-30
Completion date
2014-05-31
Last updated
2025-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Carcinoma

Brief summary

This clinical trial studies an ultrasound-based imaging procedure called elastography using the Aixplorer system in diagnosing prostate cancer in patients undergoing biopsy. Ultrasound is a non-invasive imaging technique that uses high-frequency sound waves to produce images of internal structures. Elastography uses ultrasound imaging techniques to examine the stiffness or elasticity of a tissue and may enhance the detection of prostate cancer. It is not yet known whether elastography imaging using the Aixplorer system works better than standard ultrasound imaging in detecting prostate cancer.

Detailed description

PRIMARY OBJECTIVES: I. To evaluate the detection of prostate cancer with elastography using the Aixplorer scanner. SECONDARY OBJECTIVES: I. To obtain quantitative data on the elastic properties of normal and malignant tissue in the prostate of patients referred for ultrasound guided biopsy. II. To compare the Gleason grade of prostate cancers detected with elastography to the Gleason grade of tumors detected by conventional systematic biopsy.

Interventions

PROCEDUREShear Wave Elastography

Undergo ultrasound-based elastography imaging using the Aixplorer system

Undergo ultrasound-based elastography imaging using the Aixplorer system

Undergo standard of care ultrasound-guided prostate biopsy

Sponsors

Sidney Kimmel Cancer Center at Thomas Jefferson University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Be scheduled for a clinically indicated biopsy of the prostate * Agree to an ultrasound examination using the Aixplorer system * Sign an institutional review board (IRB) approved informed consent prior to any study procedures

Exclusion criteria

• Recent prostate biopsy within 90 days

Design outcomes

Primary

MeasureTime frameDescription
Frequency of diagnosis of prostate cancer using elastography using the Aixplorer scannerAt the time of prostate biopsyWill focus on comparing the frequency of diagnosis of prostate cancer between conventional systematic biopsy and targeted biopsy based upon abnormalities in gray scale imaging, Doppler imaging, and elastography. The main parameter of interest will be the ratio of the detection frequency with targeted biopsy versus that with systematic biopsy. The analyses will be based on methods for matched data in cohort studies and will use the appropriate estimate and variance for the relative risk.

Secondary

MeasureTime frameDescription
Gleason scores of the cores detected with targeted biopsy versus those of the cores of systematic biopsyAt the time of prostate biopsyAnalyses will be carried out via the Generalized Estimating Equations methods to account for clustering within patient (multiple cores per patient).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026